CHF257.00
0.27%
SIX Swiss Exchange, Dec 06, 05:30 pm CET
ISIN
CH0012032048
Symbol
ROG
Index
Sector
Industry

Roche Target price 2024 - Analyst rating & recommendation

Roche Classifications & Recommendation:

Buy
41%
Hold
41%
Sell
18%

Roche Price Target

Target Price CHF301.79
Price CHF257.00
Potential 17.43%
Number of Estimates 19
19 Analysts have issued a price target Roche 2025 . The average Roche target price is CHF301.79. This is 17.43% higher than the current stock price. The highest price target is CHF440.00 71.21% , the lowest is CHF230.00 10.51% .
A rating was issued by 22 analysts: 9 Analysts recommend Roche to buy, 9 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Roche stock has an average upside potential 2025 of 17.43% . Most analysts recommend the Roche stock at Buy or hold.

Sales and Margin forecast 2024, 2025 to 2028


Dec '23 2024
Estimates
Revenue Billion CHF 58.72 60.69
7.21% 3.36%
EBITDA Margin 33.76% 38.26%
2.89% 13.33%
Net Margin 19.53% 21.82%
0.14% 11.74%

18 Analysts have issued a sales forecast Roche 2024 . The average Roche sales estimate is CHF60.7b . This is 3.24% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF63.3b 7.73% , the lowest is CHF59.7b 1.48% .

This results in the following potential growth metrics:

Revenue Estimates

2023 CHF58.7b 7.21%
2024 CHF60.7b 3.36%
2025 CHF64.3b 5.87%
2026 CHF67.1b 4.36%
2027 CHF70.1b 4.49%
2028 CHF72.1b 2.94%

16 Analysts have issued an Roche EBITDA forecast 2024. The average Roche EBITDA estimate is CHF23.2b . This is 17.02% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF25.8b 29.87% , the lowest is CHF20.4b 2.58% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 CHF19.8b 9.89%
2024 CHF23.2b 17.14%
2025 CHF25.1b 8.24%
2026 CHF26.4b 5.07%
2027 CHF27.7b 4.88%
2028 CHF28.3b 2.34%

EBITDA Margin

2023 33.76% 2.89%
2024 38.26% 13.33%
2025 39.12% 2.25%
2026 39.38% 0.66%
2027 39.53% 0.38%
2028 39.30% 0.58%

14 Roche Analysts have issued a net profit forecast 2024. The average Roche net profit estimate is CHF13.2b . This is 24.78% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF15.0b 41.36% , the lowest is CHF11.5b 8.41% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 CHF11.5b 7.34%
2024 CHF13.2b 15.50%
2025 CHF15.1b 13.90%
2026 CHF16.2b 7.14%
2027 CHF17.0b 5.48%
2028 CHF17.9b 5.19%

Net Margin

2023 19.53% 0.14%
2024 21.82% 11.74%
2025 23.48% 7.61%
2026 24.10% 2.64%
2027 24.33% 0.95%
2028 24.86% 2.18%

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028


Dec '23 2024
Estimates
Earnings Per Share CHF 14.39 16.62
7.34% 15.50%
P/E 15.46
EV/Sales 3.86

14 Analysts have issued a Roche forecast for earnings per share. The average Roche <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is CHF16.62 . This is 24.77% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is CHF18.83 41.37% , the lowest is CHF14.44 8.41% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 CHF14.39 7.34%
2024 CHF16.62 15.50%
2025 CHF18.93 13.90%
2026 CHF20.28 7.13%
2027 CHF21.39 5.47%
2028 CHF22.50 5.19%

P/E ratio

Current 19.29 11.12%
2024 15.46 19.85%
2025 13.58 12.16%
2026 12.67 6.70%
2027 12.01 5.21%
2028 11.42 4.91%

Based on analysts' sales estimates for 2024, the Roche stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 3.86 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 3.37 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.99 13.68%
2024 3.86 3.23%
2025 3.65 5.54%
2026 3.49 4.18%
2027 3.34 4.30%
2028 3.25 2.86%

P/S ratio

Current 3.48 10.62%
2024 3.37 3.14%
2025 3.19 5.54%
2026 3.05 4.18%
2027 2.92 4.30%
2028 2.84 2.85%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today